Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.

Eggers EL, Michel BA, Wu H, Wang SZ, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E, Greenfield AL, Demuth S, Wilson MR, Henry RG, Cree BA, Hauser SL, von Büdingen HC.

JCI Insight. 2017 Nov 16;2(22). pii: 92724. doi: 10.1172/jci.insight.92724. [Epub ahead of print]

2.

Onset of secondary progressive MS after long-term rituximab therapy - a case report.

von Büdingen HC, Bischof A, Eggers EL, Wang S, Bevan CJ, Cree BA, Henry RG, Hauser SL.

Ann Clin Transl Neurol. 2016 Dec 20;4(1):46-52. doi: 10.1002/acn3.377. eCollection 2017 Jan.

3.

Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.

Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM.

J Neurol. 2017 Feb;264(2):316-326. doi: 10.1007/s00415-016-8334-6. Epub 2016 Nov 28.

4.

Fulminant Demyelinating Diseases of the Central Nervous System.

Bevan CJ, Cree BA.

Semin Neurol. 2015 Dec;35(6):656-66. doi: 10.1055/s-0035-1564682. Epub 2015 Nov 23. Review.

PMID:
26595866
5.

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG.

JAMA Neurol. 2015 Aug;72(8):897-904. doi: 10.1001/jamaneurol.2015.0993.

6.

Precision medicine in chronic disease management: The multiple sclerosis BioScreen.

Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL.

Ann Neurol. 2014 Nov;76(5):633-42. doi: 10.1002/ana.24282. Epub 2014 Oct 14. Review.

7.

Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?

Bevan CJ, Cree BA.

JAMA Neurol. 2014 Mar;71(3):269-70. doi: 10.1001/jamaneurol.2013.5486. No abstract available. Erratum in: JAMA Neurol. 2014 Jun;71(6):803.

PMID:
24395449
8.

Association of MBP peptides with Hsp70 in normal appearing human white matter.

Lund BT, Chakryan Y, Ashikian N, Mnatsakanyan L, Bevan CJ, Aguilera R, Gallaher T, Jakowec MW.

J Neurol Sci. 2006 Nov 15;249(2):122-34. Epub 2006 Jul 13.

PMID:
16842822
9.

Unrelated patients with a rearrangement of chromosome 2 causing duplication of 2p23 and deletion of 2q37.

Armstrong L, Allanson JE, Weaver DD, Bevan CJ, Hobart HH.

Am J Med Genet A. 2005 Apr 30;134(3):299-304. Review.

PMID:
15742366
10.

Chest physiotherapy and porencephalic brain lesions in very preterm infants.

Knight DB, Bevan CJ, Harding JE, Teele RL, Kuschel CA, Battin MR, Rowley RS.

J Paediatr Child Health. 2001 Dec;37(6):554-8.

PMID:
11903834

Supplemental Content

Loading ...
Support Center